Dermatological diseases such as acne, rosacea or eczema in most cases are associated with Staphylococcus infections. Despite a range of anti-acne products present on the market, there is still a need for effective remedies especially that many staphylococcal strains are antibiotic resistance. With our new approach we want to use bacteriolytic enzyme – Auresine – to improve skin hygiene by targeted elimination of pathogenic bacteria, like Staphylococcus.
Auresine eliminates Staphylococcus very efficiently and selectively without disturbing natural skin microflora, hich is particularly important in the case of skin prone to acne, and is exceptionally stable. Moreover, the enzyme is safe for human skin cells (non-cytotoxic, non-mutagenic).